What is Henry Schein's market cap?

Henry Schein (HSIC) has a market capitalization of $9.6B and trades on NASDAQ.

What is Henry Schein's revenue and profitability?

Henry Schein generated $13.4B in trailing twelve-month revenue with net income of $395.0M, representing a net margin of 3.0%. Gross margin stands at 31.2%, with free cash flow of $445.0M. These figures are based on the Q1 2026 filing.

Who are Henry Schein's competitors?

Henry Schein's key competitors include Envista Holdings Corporation, Amazon.com, Inc., Cardinal Health, Inc., and others. These companies compete in similar markets and product categories.

Who does Henry Schein partner with?

Henry Schein's notable partners include KKR & Co. Inc..

What subsidiaries does Henry Schein have?

Henry Schein's subsidiaries include BioHorizons, Henry Schein One.

Where is Henry Schein headquartered?

Henry Schein is headquartered in United States of America and employs approximately 25,000 people. It has been publicly traded since 1995.

Henry Schein

HSIC

Henry Schein is a leading global provider of healthcare products and services primarily serving office-based dental and medical practitioners.

Market cap

$9.55B+2.5%

Revenue$13.4B+5.6%

Net income$395.0M-2.9%

Free cash flow$445.0M-19.1%

EPS (diluted)$3.31+3.1%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 5, 2026

Revenue$3.4BBeat by $25.7M EPS$1.32Beat by $0.12

Read the full report

Next report

Aug 4, 2026 (In 3 weeks)

Revenue estimate$3.4B

EPS estimate$1.22

Financials

Q1 2026

Income statement

See full

Revenue$3.4B+6.3%

Gross profit$1.1B+7.0%

Operating income$182.0M+4.0%

Net income$107.0M-2.7%

EPS (diluted)$0.92+4.5%

Balance sheet

See full

Cash & equivalents$138.0M+8.7%

Total debt$3.7B+17.2%

Total equity$3.3B-1.3%

Total assets$11.3B+7.9%

Cash flow

See full

Operating cash flow-$97.0M-362%

CapEx$25.0M-19.4%

Free cash flow-$122.0M-2,133%

Valuation & ratios

Valuation

See full

Market cap$9.55B+2.5%

Enterprise value$13.14B+6.2%

P/E24.2×+0.6×

P/S0.7×0.0×

Profitability

See full

Gross margin31.2%-0.4pp

Operating margin4.9%-0.2pp

Net margin3%-0.3pp

FCF margin3.3%-1.0pp

Returns & leverage

See full

Return on equity12%+0.2pp

Debt / equity1.1×+0.2×

Current ratio1.4×0.0×

Segments

By segment

See full

Global Distribution And Value Added Services$2.8B+6.1%

Global Specialty Products$397.0M+8.2%

Global Technology$173.0M+6.8%

Competitors

By market cap

Amazon$2.66T+12.0%

Cardinal Health$54.8B+36.8%

Henry Schein$9.6B+4.0%

Envista Holdings Corporation$4.2B+25.7%

DENTSPLY SIRONA$2.4B-25.0%

3D Systems$508.0M+127%

PDE

Pro-Dex, Inc.$198.1M+31.4%

Park Dental Partners, Inc. $90.8M—

By revenue growth

PDE

Pro-Dex, Inc.+16.4%

Amazon+14.2%

Cardinal Health+12.8%

Envista Holdings Corporation+12.2%

Henry Schein+5.6%

DENTSPLY SIRONA-1.0%

3D Systems-10.2%

By net margin

PDE

Pro-Dex, Inc.16.08%+1.5pp

Amazon10.65%+0.5pp

3D Systems4.01%+70.8pp

Henry Schein2.95%-0.3pp

Envista Holdings Corporation2.41%+47.4pp

Cardinal Health0.62%-0.1pp

DENTSPLY SIRONA-17.06%+7.4pp

Profile

Henry Schein is a leading global provider of healthcare products and services primarily serving office-based dental and medical practitioners. The company operates a vast distribution network and manufactures specialty medical products, leveraging a scale-based infrastructure to act as a single-source supplier for more than one million customers worldwide. Its value proposition centers on the 'One Schein' initiative, which integrates supply chain, equipment sales, and technology solutions to enhance clinical and administrative efficiency.

Competitive position

Henry Schein is the world's largest provider of healthcare products and services to office-based dental and medical practitioners, maintaining a dominant position through a global distribution footprint and a growing portfolio of proprietary specialty brands.

GeographiesUnited States, Germany, France, Canada, Brazil, Asia-Pacific

Customer segmentsOffice-based dental practitioners, Physician practices, Dental Service Organizations (DSOs), Group Purchasing Organizations (GPOs)

Business modelValue-added distribution, Direct-to-practitioner manufacturing, Subscription SaaS, Professional services

SuppliersThird-party medical and dental manufacturers, Raw material suppliers for implants and orthopedics, Third-party delivery and shipping services

CustomersIndividual dental and medical practitioners, Large-scale Dental Service Organizations (DSOs), Hospitals and ambulatory surgery centers, Government and institutional health clinics

CountryUnited States of America

Listed1995

Employees25.0K

CEOAndrea Albertini

SectorHealthcare

IndustryMedical - Distribution

Websitehenryschein.com

FilingsSEC EDGAR

Ask your AI about Henry Schein.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Henry Schein's market cap?: Henry Schein (HSIC) has a market capitalization of $9.6B and trades on NASDAQ.
What is Henry Schein's revenue and profitability?: Henry Schein generated $13.4B in trailing twelve-month revenue with net income of $395.0M, representing a net margin of 3.0%. Gross margin stands at 31.2%, with free cash flow of $445.0M. These figures are based on the Q1 2026 filing.
Who are Henry Schein's competitors?: Henry Schein's key competitors include Envista Holdings Corporation, Amazon.com, Inc., Cardinal Health, Inc., and others. These companies compete in similar markets and product categories.
Who does Henry Schein partner with?: Henry Schein's notable partners include KKR & Co. Inc..
What subsidiaries does Henry Schein have?: Henry Schein's subsidiaries include BioHorizons, Henry Schein One.
Where is Henry Schein headquartered?: Henry Schein is headquartered in United States of America and employs approximately 25,000 people. It has been publicly traded since 1995.